
Nextop 4.5 Injection
Marketer
Jaiwik Biotech
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Nextop 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by the physician based on the patient's condition. Strict adherence to the prescribed regimen is crucial. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea) and skin reactions (rash). Injection site reactions, such as pain, swelling, or redness, may also occur. Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, liver, or kidney issues to your doctor, who may adjust the dosage or alternative therapy. While generally considered safe during pregnancy and lactation under medical guidance, professional consultation remains essential.
Uses of Nextop 4.5 Injection
Infections caused by bacteria
Major Benefits of Nextop 4.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Nextop 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Nextop 4.5 Injection:
Administering this medication will be handled by your physician or their qualified assistant; self-medication is strongly discouraged.
How Nextop 4.5 Injection works:
Comprised of Piperacillin and Tazobactum, Nextop 4.5 Injection offers a dual-action approach to bacterial infection. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, thereby hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, bolstering Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Nextop 4.5 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The administration of Nextop 4.5 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with Nextop 4.5 Injection. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Nextop 4.5 Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with kidney impairment should use Nextop 4.5 Injection cautiously. A modified dosage of Nextop 4.5 Injection might be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Administration of Nextop 4.5 Injection to individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dose modification for Nextop 4.5 Injection is likely unnecessary in such cases. However, physician consultation is recommended.
What if you forget to take Nextop 4.5 Injection :
Omitting a scheduled dose of Nextop 4.5 Injection necessitates contacting your physician.
Facts to Know About Nextop 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
